Process for treating a liquid medium using ultrasound
View Patent ↗Devices and methods for treating, preventing from growth, and neutralizing hyperproliferative, undifferentiated, or virally infected cells in a liquid medium using high-frequency, low-energy ultrasound.
1. A method of neutralizing, removing and/or preventing the growth of hyperproliferative undifferentiated, or virally infected cells suspended in a physiological fluid comprising:
placing a compartment containing the physiological fluid in a water bath;
emitting ultrasound having a frequency higher than 100 kHz into said water bath at a power level that is about 7 mW/cm 3 , to emit an ultrasound field into said compartment; and
emitting gas comprising microbubbles into the ultrasound field in the compartment containing the physiological fluid, such that the emission of ultrasound and gas bubbles induces significant programmed cell death in the hyperproliferative, undifferentiated, or virally infected cells without causing significant cavitation or significantly heating the fluid so as to maintain the temperature of the physiological fluid at less than 40 degrees C.
2. The method according to claim 1 , wherein the microbubbles are not ozone bubbles.
3. The method according to claim 1 , wherein the microbubbles are selected from the group consisting of air and oxygen bubbles.
4. The method according to claim 1 , wherein the physiological fluid is administered to a mammal and/or extracted from a mammal.
5. The method according to claim 1 , wherein the physiological fluid is selected from the group consisting of blood, plasma, serum and cerebrospinal fluid.
6. The method according to claim 1 , wherein the average diameter of the microbubbles is less than 50 μm.
7. The method according to claim 1 , wherein the average diameter of the gas microbubbles is less than 30 μm.
8. The method according to claim 1 , wherein the ultrasound emitted into the compartment does not generate a stationary field phenomenon.
9. The method according to claim 1 , further comprising emitting light having an electromagnetic radiation mainly in the visible range into the ultrasound field.
10. The method according to claim 1 , wherein the hyperproliferative cells are selected from the group consisting of tumor cells, bone marrow cells, stem cancer cells, and precancerous cells.
11. The method of claim 1 , wherein the hyperproliferative cells are leukemic cells.
12. The method of claim 1 , further comprising supplying power to the ultrasound emitter at less than 1 W/cm 2 .